Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.892 SEK | -8.79% |
|
-1.55% | -59.45% |
Jul. 02 | NeoDynamics Secures Approval to Delist from Nasdaq First North | MT |
Jun. 18 | Norse Atlantic to Operate Boeing 787 Routes for Neos in Winter | MT |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- With regards to fundamentals, the enterprise value to sales ratio is at 0.87 for the current period. Therefore, the company is undervalued.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- One of the major weak points of the company is its financial situation.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-59.45% | 3.04M | - | ||
-30.43% | 15.32B | A | ||
-57.92% | 2.08B | C+ | ||
+20.62% | 1.9B | - | ||
-26.04% | 1.23B | - | ||
+23.04% | 1.21B | B+ | ||
+1.55% | 777M | - | ||
-37.53% | 717M | - | ||
-39.55% | 689M | - | C- | |
-29.95% | 587M | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NEOD Stock
- Ratings NEOS AB